# Long-term Trial on Growth Hormone Deficiency in Adults (GHDA)

> **NCT00184730** · PHASE3 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 86 (actual)

## Conditions studied

- Growth Hormone Disorder
- Adult Growth Hormone Deficiency

## Interventions

- **DRUG:** somatropin

## Key facts

- **NCT ID:** NCT00184730
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-11
- **Primary completion:** 2006-09
- **Final completion:** 2006-09
- **Target enrollment:** 86 (ACTUAL)
- **Last updated:** 2016-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00184730

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00184730, "Long-term Trial on Growth Hormone Deficiency in Adults (GHDA)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00184730. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*